68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

Abstract Background The purpose of this study was to evaluate the imaging properties of hepatic metastases in 68Ga-PSMA positron emission tomography (PET) in patients with prostate cancer (PC). Methods 68Ga-PSMA-PET/CT scans of PC patients available in our database were evaluated retrospectively for...

Full description

Bibliographic Details
Main Authors:	Jonathan Damjanovic, Jan-Carlo Janssen, Vikas Prasad, Gerd Diederichs, Thula Walter, Winfried Brenner, Marcus R. Makowski
Format:	Article
Language:	English
Published:	BMC 2019-06-01
Series:	Cancer Imaging
Subjects:	Liver metastasis PSMA PET/CT Prostate cancer
Online Access:	http://link.springer.com/article/10.1186/s40644-019-0220-x

Similar Items

68 Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer
by: Jonathan Damjanovic, et al.
Published: (2018-05-01)

In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2nd Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With 177Lu-PSMA
by: Vikas Prasad, et al.
Published: (2021-03-01)

68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
by: Amir Iravani, et al.
Published: (2017-12-01)

Mesorectal Lymph Node Metastases as Index Lesion in 68Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer
by: Conrad Leitsmann, et al.
Published: (2021-03-01)

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
by: Zohar Keidar, et al.
Published: (2018-11-01)

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients
by: Leon Will, et al.
Published: (2017-12-01)

Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
by: Thomas Franz Fassbender, et al.
Published: (2020-06-01)

The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01)

Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
by: Garba Haruna Yunusa, et al.
Published: (2021-07-01)

A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
by: Sara Harsini, et al.
Published: (2021-07-01)

Intra-patient comparison of physiologic 68Ga-PSMA-11 and 18F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay
by: Medhat M. Osman, et al.
Published: (2021-04-01)

The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
by: Talaat Ahmed Abd El Hameed Hassan, et al.
Published: (2020-07-01)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
by: Nina-Sophie Schmidt-Hegemann, et al.
Published: (2021-10-01)

[68Ga]Ga-PSMA-11 PET-CT: Local preliminary experience in prostate cancer biochemical recurrence patients
by: João Carvalho, et al.
Published: (2021-03-01)

68Ga–Prostate-Specific Membrane Antigen: A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma
by: Rita Chahinian, et al.
Published: (2020-07-01)

Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
by: Alberto Miceli, et al.
Published: (2021-09-01)

Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
by: Lena Thomas, et al.
Published: (2017-07-01)

Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
by: Jing Zhao, et al.
Published: (2020-12-01)

Inguino-scrotal bladder hernia: an unexpected finding on 68Ga-PSMA PET/CT
by: Shirin Shahlaei, et al.
Published: (2020-07-01)

Evaluation of [68Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
by: Manuel Weber, et al.
Published: (2021-02-01)

The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using 68Ga-PSMA PET/CT as References
by: Jianhua Jiao, et al.
Published: (2021-04-01)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
by: Nat P. Lenzo, et al.
Published: (2018-02-01)

One-year experience with 68Ga-PSMA PET/CT: applications and results in biochemical recurrence of prostate cancer
by: Luciano Monteiro Prado Júnior, et al.
Published: (2018-05-01)

68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy
by: Mikhail Kesler, et al.
Published: (2021-02-01)

Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study
by: Courtney Lawhn-Heath, et al.
Published: (2020-10-01)

Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference
by: Constantinos Zamboglou, et al.
Published: (2018-05-01)

Comparison of Regularized Reconstruction and Ordered Subset Expectation Maximization Reconstruction in the Diagnostics of Prostate Cancer Using Digital Time-of-Flight <sup>68</sup>Ga-PSMA-11 PET/CT Imaging
by: Olof Jonmarker, et al.
Published: (2021-03-01)

Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis
by: Andrei Gafita, et al.
Published: (2019-12-01)

PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings
by: Falk Gühne, et al.
Published: (2021-06-01)

Skull vault hemangioma mimicking neoplastic lesion on [68Ga]Ga-PSMA-11 PET/CT in a patient with glioblastoma: A case report
by: Aurélie Moreau, et al.
Published: (2020-12-01)

Pattern of Prostate Cancer Recurrence Assessed by <sup>68</sup>Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy
by: Ismaheel O. Lawal, et al.
Published: (2021-08-01)

Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
by: Jeremie Calais, et al.
Published: (2019-01-01)

Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
by: Céline Derwael, et al.
Published: (2020-02-01)

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
by: Qing Zhang, et al.
Published: (2017-11-01)

Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients
by: Florian Rosar, et al.
Published: (2020-05-01)

[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
by: Jonathan Kuten, et al.
Published: (2019-08-01)

Detection of a Meckel's diverticulum on PSMA PET/CT: A case report
by: Mitchell M. Huang, et al.
Published: (2020-11-01)

Cases of thyroid cartilage metastasis as abnormal findings seen in prostate cancer patients visualized by 68Ga-PSMA-11 PET/CT
by: Ayman M. Gaber, et al.
Published: (2021-05-01)

Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy
by: Helle D. Zacho, et al.
Published: (2020-04-01)

Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of <sup>68</sup>Ga-PSMA PET/CT Scans
by: Sjoerd Rijnsdorp, et al.
Published: (2021-05-01)